Successful upfront cord blood transplantation for plasma cell leukemia in the first complete response after daratumumab therapy

Plasma cell leukemia (PCL) is a rare and aggressive disease with a poor prognosis. Autologous or allogeneic stem cell transplantation (ASCT or allo-SCT) with intensive chemotherapy is performed for PCL, but their efficacy is still controversial. The efficacy of novel agents such as daratumumab for P...

Ausführliche Beschreibung